[Cardiac troponin I after heart surgery corrective operation in infancy and childhood]

J Siaplaouras1, J Thul, J C Will

  • 1Zentrum für Kinderheilkunde der Justus-Liebig-Universität Giessen Feulgenstrasse 12 35385 Giessen, Germany.

Zeitschrift Fur Kardiologie
|August 7, 2001
PubMed

Insights

Postoperative cardiac troponin I (cTNI) levels indicate myocardial damage after pediatric heart surgery. While peak levels are usually seen immediately after surgery, sustained increases after 18 hours may signal poor outcomes.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Biomarkers

Context:

  • Perioperative myocardial damage impacts postoperative cardiac function in children.
  • Cardiac troponin I (cTNI) is a specific biomarker for myocardial injury.
  • Evaluating cTNI dynamics post-pediatric cardiac operations is crucial.

Purpose:

  • To assess pre- and postoperative cTNI levels in pediatric cardiac surgery patients.
  • To analyze the pattern of cTNI elevation in the first four postoperative days.
  • To determine the prognostic value of cTNI levels after pediatric cardiac operations.

Summary:

  • Preoperative cTNI levels were normal; postoperative levels correlated with cardiopulmonary bypass duration, aortic crossclamping, operative approach, and inotropic support.
  • Highest median cTNI levels were observed after repair of tetralogy of Fallot, atrioventricular septal defect, and homograft/xenograft implantation.
  • Peak cTNI levels typically occurred immediately post-surgery, with some delayed elevations; sustained increases after 18 hours indicated poor outcomes.

Impact:

  • Postoperative cTNI levels serve as a marker for perioperative myocardial injury.
  • Understanding cTNI kinetics aids in assessing surgical trauma and ischemia.
  • Sustained or secondary cTNI increases post-18 hours can predict adverse outcomes in pediatric cardiac surgery.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...